Ultralife Corporation
Ultralife Corporation (ULBI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ulbi · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $6.66
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.83 | ↑ 2.62% |
1-day model range: $6.78–$6.89. Peak: $6.89 (+2.62%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -23.8% |
| 2028 | $4 | -32.9% |
| 2029 | $4 | -36.9% |
| 2030 | $4 | -38.8% |
| 2031 | — | -39.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ULBI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-11-15 | Benchmark | Maintains | Buy→Buy |
| 2024-06-27 | Benchmark | Maintains | Buy→Buy |
| 2024-03-05 | Benchmark | Maintains | Buy→Buy |
| 2023-08-08 | Benchmark | Maintains | Buy→Buy |
| 2013-05-02 | Ardour Capital | Downgrade ↓ | Hold→Reduce |
Wall Street analysts have recently issued updated ratings on Ultralife Corporation (ULBI) stock. Of the recent 5 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover ULBI.
Analyst Recommendation Trends
ULBI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$133M
↓ 17.7% YoY
Revenue Next Year
$153M
↑ 15.5% YoY
EPS This Year
$0.17
EPS Next Year
$0.35
↑ 105.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast ULBI EPS of $0.17 for the current fiscal year, based on estimates from 1 analysts. The ULBI revenue forecast is $133M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ULBI stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ULBI price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ULBI short-term stock prediction for tomorrow is $6.83 (+2.62%). The ULBI stock price prediction for 2027 estimates an average of $5. The ULBI stock prediction for 2030 projects a range of $4–$4.
Ultralife Corporation trades on NASDAQ under the ticker ULBI. The ULBI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ULBI forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month ULBI price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $6.66.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.